GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
-15.75%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$202M
AUM Growth
+$202M
(-33%)
Cap. Flow
-$61.2M
Cap. Flow
% of AUM
-30.26%
Top 10 Holdings %
Top 10 Hldgs %
36.94%
Holding
103
New
35
Increased
9
Reduced
21
Closed
32
Top Buys
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$7.67M |
| 2 |
Amgen
AMGN
|
$6.92M |
| 3 |
Gilead Sciences
GILD
|
$6.87M |
| 4 |
CELG
Celgene Corp
CELG
|
$6.49M |
| 5 |
Edwards Lifesciences
EW
|
$5.69M |
Top Sells
| 1 |
Biogen
BIIB
|
$12.1M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$10.8M |
| 3 |
ENDP
Endo International plc
ENDP
|
$9.56M |
| 4 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$9.04M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$7.41M |
Sector Composition
| 1 | Healthcare | 90.69% |
| 2 | Financials | 0% |
